Seppälä M - Search Results

1

Glycodelin in ovarian serous carcinoma: association with differentiation and survival.

Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Bützow R, Koistinen R. Mandelin E, et al. Among authors: seppala m. Cancer Res. 2003 Oct 1;63(19):6258-64. Cancer Res. 2003. PMID: 14559812

2

Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation.

Seppälä M, Taylor RN, Koistinen H, Koistinen R, Milgrom E. Seppälä M, et al. Endocr Rev. 2002 Aug;23(4):401-30. doi: 10.1210/er.2001-0026. Endocr Rev. 2002. PMID: 12202458 Review.

3

Maternal serum glycodelin in premature rupture of membranes.

Loukovaara M, Koistinen R, Kurki T, Seppälä M. Loukovaara M, et al. Among authors: seppala m. J Perinat Med. 2002;30(6):480-2. doi: 10.1515/JPM.2002.075. J Perinat Med. 2002. PMID: 12530104

4

Glycodelin responses to hyperinsulinaemic clamp vary according to basal serum glycodelin concentration.

Seppälä M, Mandelin E, Koistinen R, Bergholm R, Tiikkainen M, Yki-Järvinen H. Seppälä M, et al. Clin Endocrinol (Oxf). 2005 May;62(5):611-5. doi: 10.1111/j.1365-2265.2005.02269.x. Clin Endocrinol (Oxf). 2005. PMID: 15853834 Clinical Trial.

5

Glycodelin reduces breast cancer xenograft growth in vivo.

Hautala LC, Koistinen R, Seppälä M, Bützow R, Stenman UH, Laakkonen P, Koistinen H. Hautala LC, et al. Among authors: seppala m. Int J Cancer. 2008 Nov 15;123(10):2279-84. doi: 10.1002/ijc.23773. Int J Cancer. 2008. PMID: 18720404 Free article.

6

The role of glycodelin in cell differentiation and tumor growth.

Koistinen H, Hautala LC, Seppälä M, Stenman UH, Laakkonen P, Koistinen R. Koistinen H, et al. Among authors: seppala m. Scand J Clin Lab Invest. 2009;69(4):452-9. doi: 10.1080/00365510903056023. Scand J Clin Lab Invest. 2009. PMID: 19551557 Review.

7

Genomic alterations in fallopian tube carcinoma: comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis.

Pere H, Tapper J, Seppälä M, Knuutila S, Butzow R. Pere H, et al. Among authors: seppala m. Cancer Res. 1998 Oct 1;58(19):4274-6. Cancer Res. 1998. PMID: 9766651

8

Expression of glycodelin in human breast and breast cancer.

Kämäräinen M, Halttunen M, Koistinen R, von Boguslawsky K, von Smitten K, Andersson LC, Seppälä M. Kämäräinen M, et al. Among authors: seppala m. Int J Cancer. 1999 Dec 10;83(6):738-42. doi: 10.1002/(sici)1097-0215(19991210)83:6<738::aid-ijc7>3.0.co;2-f. Int J Cancer. 1999. PMID: 10597188 Free article.

9

Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells.

Koistinen H, Seppälä M, Nagy B, Tapper J, Knuutila S, Koistinen R. Koistinen H, et al. Among authors: seppala m. Am J Obstet Gynecol. 2005 Dec;193(6):1955-60. doi: 10.1016/j.ajog.2005.05.073. Am J Obstet Gynecol. 2005. PMID: 16325596

10

Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties.

Kämäräinen M, Leivo I, Koistinen R, Julkunen M, Karvonen U, Rutanen EM, Seppälä M. Kämäräinen M, et al. Among authors: seppala m. Am J Pathol. 1996 May;148(5):1435-43. Am J Pathol. 1996. PMID: 8623915 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

565 results

Search Page